Superenhancers near the KLF5 gene are focally amplified in diverse cancer types. Superenhancers near the KLF5 gene are focally amplified in diverse cancer.

Slides:



Advertisements
Similar presentations
PIK3CA gene amplification in glioblastoma and squamous cell carcinoma (SCC) of the lung. PIK3CA gene amplification in glioblastoma and squamous cell carcinoma.
Advertisements

From: Epigenetic instability of imprinted genes in human cancers
Sensitivity Analysis of the MGMT-STP27 Model and Impact of Genetic and Epigenetic Context to Predict the MGMT Methylation Status in Gliomas and Other.
Figure 1 Number of somatic mutation rates across The Cancer Genome Atlas (TCGA) projects Figure 1 | Number of somatic mutation rates across The Cancer.
Sensitivity Analysis of the MGMT-STP27 Model and Impact of Genetic and Epigenetic Context to Predict the MGMT Methylation Status in Gliomas and Other.
CDKN2A/p16 Inactivation Mechanisms and Their Relationship to Smoke Exposure and Molecular Features in Non–Small-Cell Lung Cancer  Kit W. Tam, MD, MHS,
Volume 16, Issue 10, Pages (September 2016)
Molecular Signatures for Tumor Classification
ML criticality in clinical outcome across cancer types.
Genome-Wide Identification and Validation of a Novel Methylation Biomarker, SDC2, for Blood-Based Detection of Colorectal Cancer  TaeJeong Oh, Nayoung.
Hotspot mutations drive clustering of tumor types
Plots derived from provisional TCGA data from sequencing and expression analyses of invasive breast carcinoma cases. Plots derived from provisional TCGA.
Fig. 1 Number of somatic mutations in representative human cancers, detected by genome-wide sequencing studies. Number of somatic mutations in representative.
Yang et al. SALL4 is a key regulator of survival and apoptosis in human leukemic cells. Blood. 2008;112(3):805–813. Blood Volume 114(14): October.
Volume 58, Issue 2, Pages (April 2015)
Volume 62, Issue 3, Pages (May 2016)
OTX2 is associated with higher levels of activity when paired with NEUROD1 and arranged in clusters. OTX2 is associated with higher levels of activity.
Genome-Wide Analysis of PLT2 Binding to Target Genes.
by Denes Hnisz, Abraham S. Weintraub, Daniel S
Pan-Cancer Landscape of Aberrant DNA Methylation across Human Tumors
Yang Li, Shiguo Zhou, David C. Schwartz, Jian Ma  Cell Systems 
Volume 24, Issue 12, Pages e5 (September 2018)
Examples of cancer tissue profiles.
Genome-wide analysis of p53 occupancy.
Generating ChIP-seq profiles from 18G core needle biopsies from radical prostatectomy samples. Generating ChIP-seq profiles from 18G core needle biopsies.
Chromosome 8 cDNA microarray gene expression profile of the amplified regions of 8p11–12 in SUM-44, -52, and -225 cells versus MCF10A HME control cells.
Coverage plots of H3K27ac ChIP-seq data in endometrial cancer specimens. Coverage plots of H3K27ac ChIP-seq data in endometrial cancer specimens. For the.
Volume 29, Issue 5, Pages (May 2016)
Peilin Jia, Zhongming Zhao  Cell Reports 
Volume 26, Issue 12, Pages e5 (March 2019)
Coverage plots of H3K27ac ChIP-seq data in breast cancer specimens.
Changes in histone acetylation caused by progressive mtDNA depletion occur in specific loci and are robust already at day 3. Changes in histone acetylation.
Single-cell atlas of lincRNA expression during mESC to NPC differentiation. Single-cell atlas of lincRNA expression during mESC to NPC differentiation.
Coverage plots of H3K27ac ChIP-seq data in prostate cancer specimens.
The MEG3 promoter and enhancer interact with other putative enhancers within the DLK1-MEG3–imprinted region. The MEG3 promoter and enhancer interact with.
Volume 58, Issue 2, Pages (April 2015)
Volume 13, Issue 6, Pages (November 2015)
NRG1 rearrangements are found in multiple solid tumors.
Four Key Steps Control Glycolytic Flux in Mammalian Cells
EZH2 overexpression establishes a unique and conserved super-enhancer–associated transcriptional landscape. EZH2 overexpression establishes a unique and.
Identification of chromatin modifying complex recruiting H3K9 methyltransferases. a, A MEME-ChIP analysis was performed to identify the transcription factor.
HER2 mutations identified by colorectal cancer genome sequencing studies increase cell signaling and anchorage-independent growth in a colonic epithelial.
A, PTEN loss signature score in resected SQCLC brain metastases.
CHCHD2 and EGFR protein expression in NSCLC
Histone modification status at the Tβ4 promoter and at the protein level in the HuH7 sublines. Histone modification status at the Tβ4 promoter and at the.
Transcriptional and genomic targets of EN1 in TNBC cells.
EN1-associated chromatin complexes in breast cancer cells.
Dynamic contrast-enhancement curves for patients with SLE (blue) and healthy controls (red) according to the brain regions sampled. Dynamic contrast-enhancement.
SY-1425 shows similar response in RARA-high AML cell lines to APL
Fig. 1 Number of somatic mutations in representative human cancers, detected by genome-wide sequencing studies. Number of somatic mutations in representative.
Gene expression patterns of SLC and ABC transporters in normal and tumor tissues. Gene expression patterns of SLC and ABC transporters in normal and tumor.
Frequently mutated genes in colorectal cancer.
lncRNA HOXA11-AS is overexpressed in gastric cancer tissues.
HOXA9 and STAT5 co-occupy similar genomic regions and increase JAK/STAT signaling. HOXA9 and STAT5 co-occupy similar genomic regions and increase JAK/STAT.
Correlations between comutations of HRR-BER or HRR-MMR and tumor mutational burden, neoantigen load, and MSI-H. Correlations between comutations of HRR-BER.
BRD4 expression and genomic distribution in B-CLL.
Relative frequencies of FGFR aberrations in non–small cell lung carcinoma. Relative frequencies of FGFR aberrations in non–small cell lung carcinoma. A,
Germline variants influencing primary tumor type.
A, heatmap of copy number alterations determined by array CGH for a panel of 79 frozen NSCLC samples. A, heatmap of copy number alterations determined.
EZH2-driven lung cancer as a molecularly distinct entity.
Collin Tokheim, Rachel Karchin  Cell Systems 
PTEN genotype frequently dictates PTEN expression status, but evidence of heterogeneous staining implies polyclonality within some ovarian tumors. PTEN.
The ovarian cancer cell lines modestly recapitulate the spectrum of mutations found in primary ovarian tumors. The ovarian cancer cell lines modestly recapitulate.
Driver pathways and key genes in OSCC
CASP8 mutations are associated with fewer CNAs and RAS family mutations. CASP8 mutations are associated with fewer CNAs and RAS family mutations. A, number.
Integrated analysis of gene expression and copy number alterations.
Genomic instability is a core feature of ovarian cancer that frequently involves DNA-damage repair genes. Genomic instability is a core feature of ovarian.
Genomic and proteomic profiling of ovarian cancer cell lines.
TME characteristics of TCGA-STAD subtype and cancer somatic genome.
Fig. 1. FAM83H over-expression is associated with poor prognosis of CC
Presentation transcript:

Superenhancers near the KLF5 gene are focally amplified in diverse cancer types. Superenhancers near the KLF5 gene are focally amplified in diverse cancer types. A, Copy-number profile of the 13q22.1 noncoding region from HNSC, CESC, LUSC, ESCA, BLCA, STAD, and CRC. The copy-number peak, defined by statistical analysis with GISTIC (2, 109), in HNSC is highlighted. Color code is based on lineage types: squamous cell carcinomas, blue; urothelial carcinomas, green; adenocarcinomas, orange. B, DNA rearrangement analysis of the amplified noncoding region, using whole-genome sequencing data of head and neck squamous carcinoma samples from TCGA and the LUMPY program (37), demonstrates tandem duplications, as indicated by the curves. C, The merged ChIP-seq signal of the enhancer marker H3K27ac from cell lines representing HNSC, ESCA, and STAD. Superenhancers, indicated by thin bars, are called by the ROSE pipeline (39–41) based on the H3K27ac signal enrichment. BLCA, bladder carcinoma; CESC, cervical squamous cell carcinoma; CRC, colorectal adenocarcinoma; ESCA, esophageal carcinoma; GISTIC, genomic identification of significant targets in cancer; STAD, stomach adenocarcinoma; TCGA, The Cancer Genome Atlas. Xiaoyang Zhang et al. Cancer Discov 2018;8:108-125 ©2018 by American Association for Cancer Research